Eustasius Musenge to Antirheumatic Agents
This is a "connection" page, showing publications Eustasius Musenge has written about Antirheumatic Agents.
Connection Strength
0,351
-
Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. BMC Musculoskelet Disord. 2015 May 29; 16:130.
Score: 0,121
-
A prospective study of anti-tumor necrosis factor therapy in South African rheumatoid arthritis patients. Int J Rheum Dis. 2016 Jun; 19(6):594-9.
Score: 0,111
-
Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis. Clin Rheumatol. 2012 Apr; 31(4):613-9.
Score: 0,095
-
Functional disability and health-related quality of life in South Africans with early rheumatoid arthritis. Scand J Rheumatol. 2012 Oct; 41(5):366-74.
Score: 0,025